Guardant Health director gains 232 vested RSU shares

Guardant Health, Inc. director Manuel Hidalgo Medina reported the vesting and settlement of 232 Restricted Stock Units into 232 shares of common stock on July 17, 2026.

Rhea-AI Filing Summary

Guardant Health, Inc. director Manuel Hidalgo Medina reported the vesting and settlement of 232 Restricted Stock Units into 232 shares of common stock on July 17, 2026. After these transactions he directly holds 5,306 common shares and 5,569 remaining RSUs from a four-year grant awarded July 17, 2024.

Insider Trade Summary

232 shares exercised/converted

Exercise 2 txns

Insider Hidalgo Medina Manuel

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units F1, F2	232	$0.00	$0.00
Exercise	Common Stock	232	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 5,569 contracts (Direct); Common Stock — 5,306 shares (Direct)

Footnotes (2)

1. F1. The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter.
2. F2. Not applicable for Restricted Stock Units.

Key Figures

RSUs Converted: 232 shares Common Shares Held After: 5,306 shares RSUs Remaining: 5,569 units +2 more

5 metrics

RSUs Converted 232 shares Restricted Stock Units vesting and settling into common stock on July 17, 2026

Common Shares Held After 5,306 shares Direct Guardant Health common stock holdings following the July 17, 2026 transactions

RSUs Remaining 5,569 units Restricted Stock Units held after the July 17, 2026 derivative transaction

RSU Grant Date July 17, 2024 Grant date of the four-year Restricted Stock Unit award

Initial Cliff Vest 25% Portion of RSU award that vested on July 17, 2025

Key Terms

Restricted Stock Units, derivative security, vests monthly, four-year period

4 terms

Restricted Stock Units financial

"The restricted stock unit award granted on July 17, 2024 vests over a four-year period."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

derivative security financial

"Transaction code M indicates an exercise or conversion of a derivative security."

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

vests monthly financial

"The remaining 75% vests monthly for the three-year period thereafter."

four-year period financial

"The restricted stock unit award granted on July 17, 2024 vests over a four-year period."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Manuel Hidalgo Medina report in the Guardant Health (GH) Form 4?

Manuel Hidalgo Medina reported the vesting and settlement of 232 Restricted Stock Units into 232 shares of Guardant Health common stock on July 17, 2026. These equity awards come from a four-year RSU grant originally awarded to him on July 17, 2024.

How many Guardant Health (GH) common shares does Manuel Hidalgo Medina hold after this Form 4?

Following the reported RSU vesting and share settlement, Manuel Hidalgo Medina directly holds 5,306 shares of Guardant Health common stock. This figure reflects his position immediately after the July 17, 2026 transactions disclosed in the Form 4.

How many Restricted Stock Units does Manuel Hidalgo Medina still hold in Guardant Health (GH)?

After the July 17, 2026 vesting event, Manuel Hidalgo Medina continues to hold 5,569 Restricted Stock Units. These RSUs are from an award granted on July 17, 2024 that continues to vest over a multi-year schedule described in the filing footnotes.

What is the vesting schedule of Manuel Hidalgo Medina’s RSU award at Guardant Health (GH)?

The RSU award granted on July 17, 2024 vests over four years: 25% of the shares vested on July 17, 2025, and the remaining 75% vests in equal monthly installments over the following three-year period, subject to continued service.

Did the Guardant Health (GH) Form 4 report any open-market sales of shares?

No open-market sales were reported. The Form 4 shows a derivative RSU transaction and a matching acquisition of 232 common shares through RSU vesting and settlement, with no purchase or sale transactions coded as open-market buys or sells.

What transaction code was used for the Guardant Health (GH) RSU activity and what does it mean?

The transactions use code M, indicating the exercise or conversion of a derivative security. Here, Restricted Stock Units were converted into common stock, resulting in 232 new common shares and an updated count of remaining RSUs and share holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/20/2026 - 05:07 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hidalgo Medina Manuel

(Last) (First) (Middle)

3100 HANOVER STREET

(Street)

PALO ALTO CALIFORNIA 94304

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Guardant Health, Inc. [ GH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/17/2026		M		232	A	$0	5,306	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	07/17/2026		M			232	(1)	(2)	Common Stock	232	$0	5,569	D

Explanation of Responses:

1. The restricted stock unit award granted on July 17, 2024 vests over a four-year period. 25% of the shares subject to such award vested on July 17, 2025 and the remaining 75% vests monthly for the three-year period thereafter.

2. Not applicable for Restricted Stock Units.

Remarks:

	/s/ John G. Saia, as attorney-in-fact for Manuel Hidalgo Medina	07/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)